View Product The Clinical Trial Numbers by Gender The Phase 2 trial (TRIUMPHANT-2) enrolled 338 participants across multiple dosing groups, with the 12mg cohort providing the most telling data on gender-based outcomes
Cycling recommendation: Run MT-II for 8-12 weeks, then take 4 weeks off
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
doi: 10.1007/s40261-019-00826-0 6 ElashoffMMatveyenkoAVGierBElashoffRButlerPC
The goal is to help patients lose weight safely, improve metabolism, and maintain results with healthier eating habits and consistent physical activity
Skeletal muscle atrophy results from mitochondrial toxicity in denervated skeletal muscle, which can impair the scavenging of reactive oxygen species (ROS), leading to oxidative injury and the apoptosis of skeletal muscle cells [9, 10]